Open-Label Study of the Safety and Pharmacokinetics of Solifenacin in Subjects With Hepatic Impairment

• Asıl Yazarlar: Mirjam Kuipers (Yazar), Ronald Smulders (Yazar), Walter Krauwinkel (Yazar), Timothy Hoon (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2006-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Determining the pharmacokinetics and safety of solifenacin succinate, a once-daily, oral antimuscarinic agent indicated for treatment of overactive bladder, in subjects with hepatic impairment. In this open-label study, 16 subjects (eight with moderate hepatic impairment [defined as a Child-Pugh sco...